Medtronic (MDT) terminates deal to acquire EOFlow

Medtronic (NYSE: MDT) said on December 6, 2023, based upon multiple breaches under the Agreements, it delivered notice to EOFlow that it had exercised its right to terminate the Agreements. Medtronic does not believe any termination fee is payable under the Agreements. The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.

You May Also Be Interested In

• Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
• Olenox signs LOI to acquire Wildboy Holdings and IPD for $20M
• Cosmos Health posts 29% revenue rise but widens net loss in Q2 2026